Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Liberty Health Sciences Inc. Investors (LHSIF)
LOS ANGELES--(BUSINESS WIRE)--Jan 10, 2019--Glancy Prongay & Murray LLP (“GPM”), a global investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired Liberty Health Sciences Inc. (“Liberty” or the “Company”) (OTC: LHSIF ) securities between June 28, 2018 and December 3, 2018, inclusive (the “Class Period”). Liberty investors have until March 8, 2019 to file a lead plaintiff motion.
If you are a shareholder who suffered a loss, click here to participate.
In September 2018, Liberty sold its stake in Aphria Inc. (“Aphria”). On December 3, 2018, Quintessential Capital Management and Hindenburg Research issued a report entitled “Aphria: A Shell Game with a Cannabis Business on the Side,” claiming that Aphria was part of a scheme orchestrated by a network of insiders to divert funds away from shareholders and into their own pockets.
On this news, Liberty’s stock price fell $0.36 per share, or nearly 34%, over the next two trading days to close at $0.70 on December 4, 2018, thereby injuring investors.
The complaint filed in this class action alleges that defendants made false and/or misleading statements and/or failed to disclose that: (i) Liberty, in conjunction with Aphria, was involved in a scheme whereby numerous fraudulent acquisitions and transactions were made to provide undue benefits to both companies’ insiders; and (ii) as a result, Liberty’s public statements were materially false and misleading at all relevant times.
Follow us for updates on Twitter: twitter.com/GPM_LLP.
If you purchased shares of Liberty during the Class Period you may move the Court no later than March 8, 2019 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to firstname.lastname@example.org, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190110005021/en/
CONTACT: Glancy Prongay and Murray LLP, Los Angeles
Lesley Portnoy, 310-201-9150 or 888-773-9224
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL
SOURCE: Glancy Prongay & Murray LLP
Copyright Business Wire 2019.
PUB: 01/10/2019 10:30 AM/DISC: 01/10/2019 10:30 AM